Could less apatnib be better? an exploration study of dose-effect of apatnib in 41 stage IV solid tumors.
Yingying Huang(Nanfang Hospital), Lin Li(Chinese Academy of Sciences), Xiaonan Wu(Xiamen University), Xueqing Hu(Beijing Hospital), Yunbo Zhao(University of Science and Technology of China)
Cited by 0
Related Papers
The protective role of selenium on the toxicity of cisplatin-contained chemotherapy regimen in cancer patients
|Biological Trace Element Research|1997|122
Arginine methylation of HSP70 regulates retinoid acid-mediated <i>RARβ2</i> gene activation
|Proceedings of the National Academy of Sciences|2015|71
Extracellular vesicles derived from <i>Akkermansia muciniphila</i> promote placentation and mitigate preeclampsia in a mouse model
|Journal of Extracellular Vesicles|2023|69